Goran Ando
Director at EyePoint, Inc. (EYPT)
Goran Ando has filed 12 insider reports with the SEC since March 2021, as director at EyePoint, Inc. (EYPT) and director at Selecta Biosciences Inc (RNAC). Goran Ando made no open-market purchases or sales in the last 12 months. The latest filing, on January 6, 2026, reports grant or award at EyePoint, Inc. (EYPT).
- Filings
- 12
- Companies
- 2
- Bought on market
- $39.8K
- Sold on market
- None
Companies where Goran Ando is an insider
| Company | Role | Shares held | Bought | Sold | Avg buy | Price now | Last filing |
|---|---|---|---|---|---|---|---|
| Director | 13,150 | $39.8K | $7.95 | $0.2342-97% | Jan 6, 2026 | ||
| Director | $6.14 | Jan 4, 2023 |
Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record. Price now: the latest daily close, against the average buy price.
Every filing
- Jan 2, 2026EYPTSEC Form 4 filed by Director Ando GoranForm 4Grant or award
- Jan 3, 2025EYPTSEC Form 4 filed by Director Ando GoranForm 4Grant or award
- Aug 21, 2024+$39.8KEYPTDirector Ando Goran bought $39,750 worth of shares (5,000 units at $7.95), increasing direct ownership by 61% to 13,150 unitsForm 4Open-market purchase
- Jan 5, 2024EYPTSEC Form 4 filed by Ando GoranForm 4Grant or award
- Jun 20, 2023EYPTSEC Form 4 filed by Ando GoranForm 4Grant or award
- Feb 9, 2023EYPTSEC Form 4: Ando Goran converted options into 3,250 shares, increasing direct ownership by 66% to 8,150 unitsForm 4Exercise or conversion of a derivative
- Jan 2, 2023RNACSEC Form 4 filed by Ando GoranForm 4Grant or award
- Feb 9, 2022EYPTSEC Form 4: Ando Goran converted options into 2,750 shares, increasing direct ownership by 128% to 4,900 unitsForm 4Grant or awardExercise or conversion of a derivative
- Jan 3, 2022RNACSEC Form 4 filed by Ando GoranForm 4Grant or award
- Jun 22, 2021EYPTSEC Form 4 filed by ANDO GORANForm 4Grant or award
- Mar 30, 2021RNACSEC Form 4 filed by Goran AndoForm 4Grant or award
- Feb 28, 2021EYPTSEC Form 4: Goran Ando exercised 2,150 units of Common Stock at a strike of $0.00Form 4Exercise or conversion of a derivative
Compare Goran Ando with
- Goran Ando vs George Elston1 shared
- Goran Ando vs Karen L. Zaderej1 shared
- Goran Ando vs Jay S. Duker1 shared
- Goran Ando vs Ramiro Ribeiro1 shared
- Goran Ando vs Elizabeth Hoge1 shared
- Goran Ando vs Murat Kalayoglu1 shared
Other insiders at the same companies
- George ElstonEYPT
- Karen L. ZaderejEYPT
- Jay S. DukerEYPT
- Ramiro RibeiroEYPT
- Elizabeth HogeRNAC
- Murat KalayogluRNAC
- Michael SingerRNAC
- Carsten BrunnRNAC
- Blaine DavisRNAC
- Milos MiljkovicRNAC
- Nancy LurkerEYPT
- Nishan M DeSilvaRNAC
- Kemal MalikRNAC
- Patrick J ZennerRNAC
- June Ann SeymourRNAC
- Timothy C BarabeRNAC
Questions about Goran Ando
- What is Goran Ando's role at EyePoint, Inc.?
- Goran Ando reports to the SEC as director at EyePoint, Inc. (EYPT), according to the latest filing on January 6, 2026. Goran Ando has also filed as director at Selecta Biosciences Inc (RNAC).
- How many shares does Goran Ando own?
- After the latest filing that states it, Goran Ando directly owned 13,150 shares of EyePoint, Inc. (EYPT). Shares held through trusts, funds or family members are reported separately and are not counted here.
- Has Goran Ando bought or sold stock recently?
- The most recent open-market purchase was on August 21, 2024: bought 5,000 shares of EyePoint Pharmaceuticals, Inc. (EYPT) for $39.8K at an average of $7.95.
- How do I get alerts when Goran Ando files?
- Follow Goran Ando on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale.
From SEC Forms 3, 4, 5 and 144 filed by Goran Ando (SEC CIK 0001110748). Totals count each trade once, skipping amendments whose original is on file, from Mar 3, 2021 on. View on SEC EDGAR · Get this as JSON